MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.
作者： Marc Saake , Soenke Langner , Carsten Schwenke , Marina Weibart , Olav Jansen
DOI: 10.1007/S00330-015-3889-7
关键词:
摘要: Objectives To compare contrast effects of gadobutrol with gadoterate meglumine for brain MRI in multiple sclerosis (MS) a multicentre, randomized, prospective, intraindividual study at 3 T.
springer.com
sci-hub.se 参考文章(32)
Tobias Engelhorn, Marc A. Schwarz, Ilker Y. Eyupoglu, Stephan P. Kloska, Tobias Struffert, Arnd Doerfler, Dynamic Contrast Enhancement of Experimental Glioma Academic Radiology. ,vol. 17, pp. 188- 193 ,(2010) , 10.1016/J.ACRA.2009.08.014
Maria Pia Sormani, Paolo Bruzzi, MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials Lancet Neurology. ,vol. 12, pp. 669- 676 ,(2013) , 10.1016/S1474-4422(13)70103-0
Nicoletta Anzalone, Simonetta Gerevini, Roberta Scotti, Paolo Vezzulli, Piero Picozzi, Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine. Acta Radiologica. ,vol. 50, pp. 933- 940 ,(2009) , 10.1080/02841850903095385
Massimo Filippi, Paolo Preziosa, Maria A. Rocca, Magnetic resonance outcome measures in multiple sclerosis trials Current Opinion in Neurology. ,vol. 27, pp. 290- 299 ,(2014) , 10.1097/WCO.0000000000000095
Ilana R. Leppert, S. Narayanan, D. Araújo, P. S. Giacomini, Y. Lapierre, D. L. Arnold, G. B. Pike, Interpreting therapeutic effect in multiple sclerosis via MRI contrast enhancing lesions: now you see them, now you don't. Journal of Neurology. ,vol. 261, pp. 809- 816 ,(2014) , 10.1007/S00415-014-7284-0
Nicoletta Anzalone, Tommaso Scarabino, Carlo Venturi, Concetto Cristaudo, Armando Tartaro, Giuseppe Scotti, Domenico Zimatore, Roberto Floris, Alessandro Carriero, Marcello Longo, Mario Cirillo, Maria Assunta Cova, Simona Gatti, Matthias Voth, Cesare Colosimo, Cerebral neoplastic enhancing lesions: Multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1mmolGd/kg body weight in a clinical setting European Journal of Radiology. ,vol. 82, pp. 139- 145 ,(2013) , 10.1016/J.EJRAD.2011.07.005
M. Koenig, G. Schulte-Altedorneburg, M. Piontek, A. Hentsch, P. Spangenberg, C. Schwenke, A. Harders, L. Heuser, Intra-individual, randomised comparison of the MRI contrast agents gadobutrol versus gadoteridol in patients with primary and secondary brain tumours, evaluated in a blinded read European Radiology. ,vol. 23, pp. 3287- 3295 ,(2013) , 10.1007/S00330-013-2946-3
M. Filippi, T. Yousry, M. A. Rocca, G. Fesl, R. Voltz, G. Comi, Sensitivity of delayed gadolinium-enhanced MRI in multiple sclerosis Acta Neurologica Scandinavica. ,vol. 95, pp. 331- 334 ,(1997) , 10.1111/J.1600-0404.1997.TB00220.X
Michael Ingrisch, Steven Sourbron, Dominik Morhard, Birgit Ertl-Wagner, Tania Kümpfel, Reinhard Hohlfeld, Maximilian Reiser, Christian Glaser, Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T. Investigative Radiology. ,vol. 47, pp. 252- 258 ,(2012) , 10.1097/RLI.0B013E31823BFC97
G??raldine Le Duc, St??phanie Corde, Anne-Marie Charvet, H??l??ne Elleaume, R??gine Farion, Jean-Fran??ois Le Bas, Fran??ois Est??ve, In vivo measurement of gadolinium concentration in a rat glioma model by monochromatic quantitative computed tomography: comparison between gadopentetate dimeglumine and gadobutrol. Investigative Radiology. ,vol. 39, pp. 385- 393 ,(2004) , 10.1097/01.RLI.0000124250.61768.C0